Bupropion Does Not Typically Cause Fatigue
Bupropion is generally associated with increased energy and stimulation rather than fatigue, though paradoxically, fatigue can occur as a side effect in a small percentage of patients.
Primary Evidence from FDA Labeling
The FDA-approved prescribing information for bupropion does not list fatigue as a common adverse reaction in the main adverse event tables. In controlled trials, somnolence (which encompasses fatigue/drowsiness) occurred in only 2-3% of patients across different formulations, with rates similar to or only slightly higher than placebo 1. This is notably lower than the incidence of activating side effects like insomnia (6-20%), agitation (2-9%), and anxiety (3-7%).
Mechanism and Expected Effects
Bupropion's pharmacology predicts an activating rather than sedating profile. As a norepinephrine and dopamine reuptake inhibitor with stimulant-like properties, it typically increases motor activity and alertness 1. The drug exhibits "mild amphetamine-like activity" in controlled studies and increases locomotor activity in animal models 1.
Clinical Context: When Fatigue Does Occur
While uncommon, fatigue/drowsiness has been reported:
- In combination therapy: When bupropion was combined with duloxetine for treatment-resistant depression, 2 out of 10 patients (20%) reported fatigue/drowsiness 2
- Postmarketing reports: The FDA label notes "malaise" and general fatigue in voluntary postmarketing surveillance, though frequency cannot be reliably estimated 1
- Recent comparative data: Bupropion augmentation specifically outperformed buspirone for reducing fatigue in STAR*D Level 2 (n=520, difference = -0.322, pFWER=0.005), suggesting it actually improves fatigue symptoms 3
Clinical Implications
If a patient reports fatigue on bupropion, consider:
- Baseline depression symptoms: Fatigue is a core symptom of depression itself; the medication may not yet be fully effective
- Dose-related effects: Higher doses may paradoxically cause fatigue in some individuals
- Sleep disruption: Bupropion-induced insomnia (6-20% incidence) can secondarily cause daytime fatigue 1
- Drug interactions: Combination with other medications may alter the side effect profile 2
- Individual variation: A small subset of patients may experience atypical responses
Bottom Line
Bupropion's adverse event profile from controlled trials and FDA labeling consistently shows it is an activating antidepressant. The 2008 American College of Physicians guideline notes that trazodone was associated with higher somnolence than bupropion, reinforcing bupropion's non-sedating profile 4. Fatigue occurs in only 2-3% of patients—comparable to placebo rates—making it an uncommon rather than characteristic side effect of this medication.